Last update 23 Jan 2025

RNA x OTCase

Basic Info

Related Targets
RNAOTCase

Related

1
Drugs associated with RNA x OTCase
MRT-5201
Target
OTCase x RNA
Mechanism
OTCase stimulants [+1]
Active Org.-
Originator Org.
Translate Bio, Inc.Translate Bio, Inc.
Active Indication-
Inactive Indication
Ornithine Carbamoyltransferase Deficiency Disease
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with RNA x OTCase
NCT03767270
/ WithdrawnPhase 1/2
A Phase 1/2 Single Ascending Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenously Administered MRT5201 in Subjects With Ornithine Transcarbamylase Deficiency
100 Clinical Results associated with RNA x OTCase
Login to view more data
100 Translational Medicine associated with RNA x OTCase
Login to view more data
0 Patents (Medical) associated with RNA x OTCase
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free